First National Corp Bristol Myers Squibb CO Transaction History

First National Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 30, 2019	SELL	$44.62 - $49.34 $35,339 - $39,077	-792 Closed	0 $0
Q1 2019 Jun 12, 2019	SELL	$45.12 - $53.8 $7,083 - $8,446	-157 Reduced 16.54%	792 $1.61 Million
Q4 2018 Jun 12, 2019	BUY	$48.76 - $63.23 $46,273 - $60,005	949 New	949 $49,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of First National Corp , based on Form 13F filings with the SEC.

Stay updated on First National Corp with notifications on news.